{{Rsnum
|rsid=2234889
|Gene=FMO2
|Chromosome=1
|position=171209118
|Orientation=plus
|GMAF=0.1488
|Gene_s=FMO2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(-;-)
|geno2=(-;T)
|geno3=(T;T)
}}{{PharmGKB
|RSID=rs2234889
|Name_s=g.23,412dupT, p.C530fs
|Gene_s=FMO2
|Feature=
|Evidence=PubMed ID:15864117; PubMed ID:15922018; PubMed ID:18423897
|Annotation=The g.23,412dupT variant segregates with, and is secondary to, g.23,238C>T. The allele containing both of these polymorphisms has been designated FMO2*2A. and encodes a truncated, inactive protein.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161660838
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}